Evommune, Inc. Common Stock (EVMN)
EBITDA
-$34.34M
Quarterly · Period ending: · USD
EVMN EBITDA
Latest reported-$34.34Mperiod ending
Latest reported-$34.34Mperiod ending
EVMN Quarterly EBITDA (-$2.50M → -$34.34M)
Quarterly EBITDA
High-resolution chart · PNG
EVMN ebitda history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| -34,343,000 | |
| -23,605,000 | |
| -29,390,000 | |
| -13,017,000 | |
| -13,187,000 | |
| -14,176,000 | |
| -17,961,000 | |
| -16,186,000 | |
| -27,048,000 | |
| -2,502,000 |